EXHIBIT A

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Skye Bioscience, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.

 

Dated: August 28, 2023

 

5AM Ventures VII, L.P.   5AM Partners VII, LLC
     
By: 5AM Partners VII, LLC   By: /s/ Andrew J. Schwab
its General Partner     Name: Andrew J. Schwab
      Title: Managing Member
By: /s/ Andrew J. Schwab    
  Name: Andrew J. Schwab    
  Title: Managing Member    
     
5AM Ventures II, L.P.   5AM Partners II, LLC
     
By: 5AM Partners II, LLC   By: /s/ Andrew J. Schwab
its General Partner     Name: Andrew J. Schwab
      Title: Managing Member
By: /s/ Andrew J. Schwab    
  Name: Andrew J. Schwab    
  Title: Managing Member    
     
5AM Co-Investors II, L.P.    
     
By: 5AM Partners II, LLC    
its General Partner    
     
By: /s/ Andrew J. Schwab    
  Name: Andrew J. Schwab    
  Title: Managing Member    
     
/s/ Andrew J. Schwab    
Andrew J. Schwab    
     
/s/ Dr. Kush Parmar    
Dr. Kush Parmar    
     
/s/ Dr. John D. Diekman    
Dr. John D. Diekman    
     
/s/ Dr. Scott M. Rocklage    
Dr. Scott M. Rocklage